News & Updates
Showing Pharmacy articles
Showing
Show Multimedia Only

Are SGLT2 inhibitors cardioprotective in wild-type ATTR-CM patients?
05 Nov 2024
byAudrey Abella
The use of sodium glucose cotransporter-2 (SGLT2) inhibitors nearly halves the risk of all-cause mortality at 3 years in patients with wild-type transthyretin amyloid cardiomyopathy (ATTR-CM) and type 2 diabetes (T2D), findings from an observational study suggest.
05 Nov 2024

Opioid does little to ease pain in aSAH-related headache
04 Nov 2024
Use of opioids results in small reductions in pain among adult patients with an aneurysmal subarachnoid haemorrhage (aSAH)-related headache, and higher doses do not appear to significantly boost its efficacy in relieving pain, according to a study.
04 Nov 2024






